Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells

Oncogene

Volumn 32, Issue 38, 2013, Pages 4509-4518

  Lin, Y H ^a   Liao, C J ^a   Huang, Y H ^b   Wu, M H ^a   Chi, H C ^a   Wu, S M ^a   Chen, C Y ^a   Tseng, Y H ^a   Tsai, C Y ^a   Chung, I H ^a   Wu, T I ^a   Tsai, M M ^c   Lin, C D ^d   Lin, K H ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d PACIFIC UNION COLLEGE   (United States)

Author keywords

hepatocellular carcinoma; matrix metalloproteinases 3; microRNA; p AKT; thyroid hormone

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; LUCIFERASE; MICRORNA; MICRORNA 17; PROTEIN KINASE B; STROMELYSIN; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MEDIATOR; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPORTER GENE; TRANSCRIPTION REGULATION; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERTHYROIDISM; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 3; MICRORNAS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, THYROID HORMONE; RESPONSE ELEMENTS; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONES;

EID: 84884589560     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.309     Document Type: Article

References (38)

1. Huang YH, Tsai MM, Lin KH. Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med J 2008; 31: 325-334.
2. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81: 1097-1142.
3. Cheng SY. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 2000; 1: 9-18.
4. Thormeyer D, Baniahmad A. The v-erbA oncogene (review). Int J Mol Med 1999; 4: 351-358.
5. Barrera-Hernandez G, Park KS, Dace A, Zhan Q, Cheng SY. Thyroid hormoneinduced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclindependent kinase levels and activity. Endocrinology 1999; 140: 5267-5274.
6. Hall LC, Salazar EP, Kane SR, Liu N. Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 2008; 109: 57-66.
7. Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 2008; 68: 610-619.
8. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 2006; 66: 7270-7275.
9. Lai EC. Micro RNAs are complementary to 30 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-364.
10. Tsang YS, Lo KW, Leung SF, Choi PH, Fong Y, Lee JC et al. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 1999; 83: 305-308.
11. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999-3004.
13. Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, Huang GT et al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: Identification of three independent regions. Eur J Cancer 1999; 35: 1730-1734.
14. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H et al. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991; 48: 550-556.
15. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 1996; 69: 9-16.
16. Bramhall SR, Stamp GW, Dunn J, Lemoine NR, Neoptolemos JP. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996; 73: 972-978.
17. Okamoto K, Ishida C, Ikebuchi Y, Mandai M, Mimura K, Murawaki Y et al. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med 2010; 49: 887-895.
18. Lin KH, Shieh HY, Hsu HC. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 2000; 141: 2540-2547.
19. Nakano K, Matsushita A, Sasaki S, Misawa H, Nishiyama K, Kashiwabara Y et al. Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: Study with a new experimental system using CV1 cells. Biochem J 2004; 378(Pt 2): 549-557.
20. Chi HC, Chen SL, Liao CJ, Liao CH, Tsai MM, Lin YH et al. Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. Cell Death Differ 2012; 19: 1802-1814.
21. Chen RN, Huang YH, Lin YC, Yeh CT, Liang Y, Chen SL et al. Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology 2008; 149: 3817-3831.
22. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11: 1031-1038.
23. Li H, Bian C, Liao L, Li J, Zhao RC. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 2011; 126: 565-575.
24. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008; 182: 509-517.
25. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.Proc Natl Acad Sci USA 2010; 107: 8231-8236.
26. Yang F, Yin Y, Wang F, Wang Y, Zhang L, Tang Y et al. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogenactivated protein kinase-heat shock protein 27 pathway. Hepatology 2010; 51: 1614-1623.
27. Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR, Wu TS et al. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol 2013; S1040-8428: 00070-0007.
28. Zhang M, Dai C, Zhu H, Chen S, Wu Y, Li Q et al. Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. Mol Cell Biochem 2011; 357: 387-395.
29. Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, Ng IO. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 2011; 53: 1558-1569.
30. Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011; 30: 2057-2069.
31. Chen CY, Chi LM, Chi HC, Tsai MM, Tsai CY, Tseng YH et al. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells. Mol Cell Proteomics 2012; 11: M111 011270.
32. Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY et al. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 2010; 138: 1863-1874.
33. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 1979; 105: 80-85.
34. Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 2010; 46: 2828-2836.
35. Liao CH, Yeh SC, Huang YH, Chen RN, Tsai MM, Chen WJ et al. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion. Endocr Relat Cancer 2010; 17: 99-111.
36. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM et al. Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Cancer Sci 2011; 102: 2255-2263.
37. Huang YH, Liao CH, Chen RN, Liao CJ, Lin KH. Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling. J Cell Physiol 2010; 222: 347-356.
38. Lin Y-H, Huang Y-H, Wu M-H, Wu S-M, Chi H-C, Liao C-J et al. Thyroid hormone suppresses cell proliferation through endoglin-ediated promotion of p21 stability. Oncogene 2013; 32: 3904-3914.